X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A | 2022-05-10 | PEPG | Oxford Science Enterprises Plc | 10% | P - Purchase | $12.00 | +879,970 | 4,755,388 | +23% | +$10,559,640 | |||||
2024-02-09 | PEPG | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $10.64 | +2,557,593 | 10,689,545 | +31% | +$27,212,790 | ||||||
2023-11-30 | PEPG | McArthur James G | Pres, CEO | P - Purchase | $4.17 | +1,694 | 1,694 | New | +$7,056 | ||||||
D | 2023-06-08 | PEPG | McArthur James G | Pres, CEO | S - Sale+OE | $16.04 | -2,381 | 0 | -100% | -$38,188 | |||||
DM | 2023-06-06 | PEPG | McArthur James G | Pres, CEO | S - Sale+OE | $16.19 | -26,569 | 0 | -100% | -$430,277 | |||||
DM | 2023-06-02 | PEPG | McArthur James G | Pres, CEO | S - Sale+OE | $16.04 | -2,300 | 0 | -100% | -$36,891 | |||||
D | 2023-03-24 | PEPG | Goyal Jaya | EVP, Res., Preclin. Dev. | S - Sale+OE | $20.00 | -392 | 0 | -100% | -$7,840 | |||||
DM | 2023-02-06 | PEPG | Goyal Jaya | EVP, Res., Preclin. Dev. | S - Sale+OE | $17.12 | -6,000 | 0 | -100% | -$102,728 | |||||
2022-05-06 | PEPG | Keating Laurie | Dir | P - Purchase | $12.00 | +4,166 | 4,166 | New | +$49,992 | ||||||
D | 2022-05-10 | PEPG | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $12.00 | +3,229,200 | 207,672 | -107% | +$38,750,400 | |||||
D | 2022-05-10 | PEPG | Flynn James E | Possible Member of 10% Group, 10% | P - Purchase | $12.00 | +416,666 | 953,626 | +78% | +$4,999,992 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |